Floatz logo

ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT

Systemic Sclerosis

Fred Hutchinson Cancer Centerother_biologicalPhase 2Dormant
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

25 Active assets in the Systemic Sclerosis cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Royal Brompton & Harefield NHS Foundation Trust
Phase 2/3BB
Iloprost
National Center for Research Resources (NCRR)
Phase 3BB
Bosentan
Actelion
Phase 3B
Rituximab
Royal Brompton & Harefield NHS Foundation Trust
Phase 2/3B
RECOMBINANT HUMANISED IgG1 KAPPA ANTI-ONCOSTATIN M MONOCLONAL ANTIBODY GSK2330811
GlaxoSmithKline
Phase 2B

View all 41 →

Same molecule, other indications

ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT is also rated in:

myelodysplastic/myeloproliferative neoplasmActive
BBB
Indicative · Phase 2/3
75 / 100
View asset →
plasma cell myelomaActive
BBB
Indicative · Phase 4
72 / 100
View asset →
myeloproliferative neoplasmActive
BB
Indicative · Phase 2/3
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →